z-logo
Premium
Suppression of Ca 2+ signals by EGR 4 controls Th1 differentiation and anti‐cancer immunity in vivo
Author(s) -
MookerjeeBasu Jayati,
Hooper Robert,
Gross Scott,
Schultz Bryant,
Go Christina K,
Samakai Elsie,
Ladner Jonathan,
Nicolas Emmanuelle,
Tian Yuanyuan,
Zhou Bo,
Zaidi M Raza,
Tourtellotte Warren,
He Shan,
Zhang Yi,
Kappes Dietmar J,
Soboloff Jonathan
Publication year - 2020
Publication title -
embo reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.584
H-Index - 184
eISSN - 1469-3178
pISSN - 1469-221X
DOI - 10.15252/embr.201948904
Subject(s) - in vivo , immunity , chemistry , microbiology and biotechnology , cancer , biology , immune system , cancer research , immunology , genetics
While the zinc finger transcription factors EGR 1, EGR 2, and EGR 3 are recognized as critical for T‐cell function, the role of EGR 4 remains unstudied. Here, we show that EGR 4 is rapidly upregulated upon TCR engagement, serving as a critical “brake” on T‐cell activation. Hence, TCR engagement of EGR 4 −/− T cells leads to enhanced Ca 2+ responses, driving sustained NFAT activation and hyperproliferation. This causes profound increases in IFN γ production under resting and diverse polarizing conditions that could be reversed by pharmacological attenuation of Ca 2+ entry. Finally, an in vivo melanoma lung colonization assay reveals enhanced anti‐tumor immunity in EGR 4 −/− mice, attributable to Th1 bias, Treg loss, and increased CTL generation in the tumor microenvironment. Overall, these observations reveal for the first time that EGR 4 is a key regulator of T‐cell differentiation and function.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom